MedTrace Logo

Sleep Restriction Therapy (SRT) for Sleep Problems in Children With Autism

NCT06627205 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2025-05-16

No results posted yet for this study

Summary

The purpose of this open label trial is to examine the acceptability, tolerability, and feasibility and preliminary effectiveness of sleep restriction therapy for sleep problems in children with autism spectrum disorder (ASD). Treatment will be delivered via secure telemedicine platform and consist of parent-training in delivering the intervention.

Conditions

  • Autism Spectrum Disorder (ASD)
  • Autism

Interventions

BEHAVIORAL

Sleep Restriction Therapy

Therapist led sleep restriction therapy sessions.

Sponsors & Collaborators

Principal Investigators

  • Emma K Baker, MPsych(Clin), PhD · Stanford University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-11
Primary Completion
2026-12-31
Completion
2027-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06627205 on ClinicalTrials.gov